A woman was left heartbroken after her husband died days after returning from a drug trial. Malcolm Williams was diagnosed ...

Lauren Williams, 74, is trying to raise awareness about the dangers of experimental trials after her husband Malcolm, a ...

A new treatment for advanced endometrial cancer has been approved for use on the NHS, after women with the disease were found ...

A man who 'jumped at the opportunity' to take part in a miracle drug trial died with days of starting the treatment, says his ...

Two days after being taken to hospital Malcolm, a dad-of-four and who was "worshipped" by his three step-children, was ...

A leading scientist, a businesswoman and a disease-free patient come together to tell the full story of the promising ...

CytomX Therapeutics' innovative cancer therapies show promise with the CX-2051 and CX-801 trials. Explore the potential of ...

For patients with advanced renal cell carcinoma (RCC), there is a sustained clinical benefit with pembrolizumab plus axitinib ...

A study reveals real-world outcomes of neoadjuvant immune checkpoint inhibitors in nonmetastatic colon cancer, highlighting ...

The study began on April 11, 2021, and was last updated on August 4, 2025. However, it has been terminated, which could impact the timeline for any potential market release of SAR444881.

A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published in Nature Medicine.

New first-line option for patients with pMMR and dMMR tumours in England NICE has recommended KEYTRUDA (pembrolizumab) with ...